A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.

doi:10.1007/s12032-014-0267-2

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.

Medical oncology (Northwood, London, England) - 1 Nov 2014

Tang Qiushi, Zhao Ying, Wang Yulin, Wei Minjie

Abstract excerpt

Experimental and epidemiologic studies indicated that calcium-sensing receptor (CaSR) polymorphisms were associated with cancer risk, yet no data are available for candidate gene and hepatocellular carcinoma (HCC) risk. To address this, we evaluated whether CaSR rs17251221 polymorphism is associated with HCC susceptibility, clinicopathological parameters, and prognosis in HCC patients treated by TACE. A TaqMan...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Antineoplastic Combined Chemotherapy Protocols

Share to Carcinoma, Hepatocellular

Share to Case-Control Studies

Share to Cohort Studies

Share to Liver Neoplasms

Share to Receptors, Calcium-Sensing

Source

Open in PubMed

Identifiers

PMID: 25270285
DOI: 10.1007/s12032-014-0267-2

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.PMID 25270285Read ↗

A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with breast cancer susceptibility and prognosis.Semantic proximity Read ↗

A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with ovarian cancer susceptibility.Semantic proximity Read ↗

Genetic polymorphism of calcium-sensing receptor in women with breast cancer.Semantic proximity Read ↗

The Effect of SNPs in lncRNA As ceRNA on the Risk and Prognosis of Hepatocellular CarcinomaSemantic proximity Read ↗

A Case-Control Study on the Correlation Between Thymidylate Synthase Gene Polymorphisms and Raltitrexed Treatment Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Treatment.Semantic proximity Read ↗

Association Between P2RX7 Gene and Hepatocellular Carcinoma Susceptibility: A Case-Control Study in a Chinese Han Population.Semantic proximity Read ↗

The effect of SNPs in lncRNA as ceRNA on the risk and prognosis of hepatocellular carcinoma.Semantic proximity Read ↗

The Effect of SNPs in IncRNA as CeRNA on The Risk and Prognosis of Hepatocellular CarcinomaSemantic proximity Read ↗

Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.Semantic proximity Read ↗

CASR rs1801725 polymorphism is associated with the risk and prognosis of colorectal cancer: A case-control study.Semantic proximity Read ↗

Genetic biomarkers for hepatocellular cancer risk in a caucasian population.Semantic proximity Read ↗

An insertion/deletion polymorphism in the 3' untranslated region of type I collagen a2 (COL1A2) is associated with susceptibility for hepatocellular carcinoma in a Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.